Search global stocks & ETFs...Ctrl K
Learn Mode
IQV
Stock Profile
07-28
Recommended Metric
Score Card
Explore Scores Tab
3.50
Good
Valuation Score
Key Score
4.00
Good
Management
3.00
Average
Growth
5.00
Very Good
Profitability
3.00
Average
Fin. Health
2.00
Bad
Dividends
--
--
Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$207.04
Baseline
High
$301.35
▲
45.55%
Avg
$235.82
▲
13.90%
Low
$196.95
▼
-4.87%
Analyst Ratings based on 30 Analysts
Strong Buy
930%
Buy
1550%
Hold
620%
Sell
000%
Strong Sell
000%
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.Read More